Ponzo, M.; Debesset, A.; Cossutta, M.; Chalabi-Dchar, M.; Houppe, C.; Pilon, C.; Nicolas-Boluda, A.; Meunier, S.; Raineri, F.; Thiolat, A.;
et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265.
https://doi.org/10.3390/cancers14174265
AMA Style
Ponzo M, Debesset A, Cossutta M, Chalabi-Dchar M, Houppe C, Pilon C, Nicolas-Boluda A, Meunier S, Raineri F, Thiolat A,
et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers. 2022; 14(17):4265.
https://doi.org/10.3390/cancers14174265
Chicago/Turabian Style
Ponzo, Matteo, Anais Debesset, Mélissande Cossutta, Mounira Chalabi-Dchar, Claire Houppe, Caroline Pilon, Alba Nicolas-Boluda, Sylvain Meunier, Fabio Raineri, Allan Thiolat,
and et al. 2022. "Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression" Cancers 14, no. 17: 4265.
https://doi.org/10.3390/cancers14174265
APA Style
Ponzo, M., Debesset, A., Cossutta, M., Chalabi-Dchar, M., Houppe, C., Pilon, C., Nicolas-Boluda, A., Meunier, S., Raineri, F., Thiolat, A., Nicolle, R., Maione, F., Brundu, S., Cojocaru, C. F., Bouvet, P., Bousquet, C., Gazeau, F., Tournigand, C., Courty, J.,
... Cascone, I.
(2022). Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers, 14(17), 4265.
https://doi.org/10.3390/cancers14174265